LoginRegister
    Man dies after Pharmacist administers painkiller injection; case bookedMan dies after Pharmacist administers painkiller injection; case booked
    Zydus Cadila launches Ramelteon tablets in US to treat insomniaZydus Cadila launches Ramelteon tablets in US to treat insomnia
    Manipal Group Stempeutics, Kemwell strike deal worth Rs 95 crore for global commercialisation of StempeucelManipal Group Stempeutics, Kemwell strike deal worth Rs 95 crore for global commercialisation of...
    Syngene International Q1 net profit rises 9 percent to Rs 72 croreSyngene International Q1 net profit rises 9 percent to Rs 72 crore
    Merck biosimilar to AbbVie blockbuster Humira wins USFDA approvalMerck biosimilar to AbbVie blockbuster Humira wins USFDA approval
    Pfizer gets USFDA nod for biosimilar to RituximabPfizer gets USFDA nod for biosimilar to Rituximab
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory...
    Alembic Pharma gets tentative USFDA nod for Dapagliflozin Tablets to improve glycemic controlAlembic Pharma gets tentative USFDA nod for Dapagliflozin Tablets to improve glycemic control
    Dr Reddys unveils generic version of Rozerem Tablets in US for treating insomniaDr Reddys unveils generic version of Rozerem Tablets in US for treating insomnia
    Torrent Pharma Q1 net profit up 33 percent to Rs 216 croreTorrent Pharma Q1 net profit up 33 percent to Rs 216 crore
    Sanofi strikes deal for US rights to Roche TamifluSanofi strikes deal for US rights to Roche Tamiflu
    Revamped OxyContin was supposed to reduce abuse, but has it?Revamped OxyContin was supposed to reduce abuse, but has it?
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X